STAT+: Pharmalittle: Glaxo and Vir antibody remains effective against Omicron; Biden talks up drug-pricing reform
GlaxoSmithKline and Vir Biotechnology reported their Covid-19 antibody treatment retained effectiveness against the Omicron variant in laboratory studies.
Top of the morning to you, and a fine one it is. Sunny skies and nippy winds are enveloping the Pharmalot campus, where
